Concepedia

A two-part Phase II study of cediranib in patients with advanced solid tumours: the effect of food on single-dose pharmacokinetics and an evaluation of safety, efficacy and imaging pharmacodynamics

Claire L. Mitchell, James P.B. O’Connor, Caleb Roberts, Y. Watson, Alan Jackson, Susan Cheung, Jeffrey Evans, James Spicer, Adrian L. Harris, Claudia S. Kelly,

Cancer Chemotherapy and Pharmacology · 2010 · 24 citations · 18 references

DOIFull text

Open access

Concepts

References

18

New Guidelines to Evaluate the Response to Treatment in Solid Tumors

Patrick Therasse, Susan G. Arbuck, Elizabeth A. Eisenhauer et al. · JNCI Journal of the National Cancer Institute · 2000 · 15.7K citations

, , +12

Stereotaxic Display of Brain Lesions

Chris Rorden, Matthew Brett · Behavioural Neurology · 2000 · 2.6K citations · Full text

, , +16

AZD2171, a Pan-VEGF Receptor Tyrosine Kinase Inhibitor, Normalizes Tumor Vasculature and Alleviates Edema in Glioblastoma Patients

Tracy T. Batchelor, A. Gregory Sorensen, Emmanuelle di Tomaso et al. · Cancer Cell · 2007 · 1.8K citations · Full text

, , +17

AZD2171: A Highly Potent, Orally Bioavailable, Vascular Endothelial Growth Factor Receptor-2 Tyrosine Kinase Inhibitor for the Treatment of Cancer

Stephen R. Wedge, Jane Kendrew, Laurent Hennequin et al. · Cancer Research · 2005 · 711 citations · Full text

, , +17

Experimentally‐derived functional form for a population‐averaged high‐temporal‐resolution arterial input function for dynamic contrast‐enhanced MRI

Geoff J.M. Parker, Caleb Roberts, Andrew Macdonald et al. · Magnetic Resonance in Medicine · 2006 · 664 citations · Full text

, , +12